EW - Company ID 0001099800
Edwards Lifesciences Corp (EW) reported revenue of $6.07B for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $6.07B | +11.5% |
| FY 2024 | $5.44B | +8.6% |
| FY 2023 | $5.01B | +12.2% |
| FY 2022 | $4.46B | -14.7% |
| FY 2021 | $5.23B | +19.3% |
| FY 2020 | $4.39B | +0.9% |
| FY 2019 | $4.35B | +16.8% |
| FY 2018 | $3.72B | +8.4% |
| FY 2017 |
Edwards Lifesciences Corp (EW) reported revenue of $6.07B for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2011 and fiscal 2025, Edwards Lifesciences Corp's revenue grew from $1.68B to $6.07B.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $3.44B |
| +15.9% |
| FY 2016 | $2.96B | +18.8% |
| FY 2015 | $2.49B | +7.4% |
| FY 2014 | $2.32B | +13.6% |
| FY 2013 | $2.05B | +7.7% |
| FY 2012 | $1.90B | +13.2% |
| FY 2011 | $1.68B | - |